Related references
Note: Only part of the references are listed.Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT2a Receptor Antagonists
Michael Poyurovsky et al.
DRUGS (2020)
The Assessment and Treatment of Antipsychotic-Induced Akathisia
Tamara Pringsheim et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2018)
Management of common adverse effects of antipsychotic medications
T. Scott Stroup et al.
WORLD PSYCHIATRY (2018)
Revisiting Antipsychotic-induced Akathisia: Current Issues and Prospective Challenges
Haitham Salem et al.
CURRENT NEUROPHARMACOLOGY (2017)
Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset
F. Berna et al.
SCHIZOPHRENIA RESEARCH (2015)
Mirtazapine for antipsychotic-induced acute akathisia: a systematic review and meta-analysis of randomized placebo-controlled trials
Samir Kumar Praharaj et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2015)
Trazodone for the Treatment of Neuroleptic-Induced Acute Akathisia: A Placebo-Controlled, Double-Blind, Crossover Study
Rafael Stryjer et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Akathisia and second-generation antipsychotic drugs
Rajeev Kumar et al.
CURRENT OPINION IN PSYCHIATRY (2009)
Low-dose mirtazapine: A new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial
Michael Poyurovsky et al.
BIOLOGICAL PSYCHIATRY (2006)
Anticholinergics for neuroleptic-induced acute akathisia
J. Rathbone et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2006)
Cyproheptadine versus propranolol for the treatment of acute neuroleptic-induced akathisia: A comparative double-blind study
T Fischel et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Share Paper
